Business Context and Reporting Period
Company: Creative Medical Technology Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 19, 2018
Reporting Period: Event-based report for June 19, 2018.
The Company, a Nevada corporation, announced the formation of a new majority-owned subsidiary, CaverStem International LLC. This subsidiary is focused on commercializing stem cell therapy for erectile dysfunction to international physicians and patients.
Key Financial Metrics
This filing is an event report (Item 8.01 Other Events) and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
The material change reported is the strategic expansion of the Company's operations through the creation of CaverStem International LLC. No financial performance changes versus prior periods are disclosed in this document.
Guidance, Outlook, and Risks
- Outlook: The press release furnished as Exhibit 99.1 contains forward-looking statements regarding the commercialization of stem cell therapy.
- Risks: Management cautions that actual results could differ materially from anticipated results due to various factors.
- Contingencies: The Company assumes no duty or obligation to update or revise forward-looking statements, though it may do so via future reports or press releases.
- Reference: Investors are directed to the Annual Report on Form 10-K for the year ended December 31, 2017, for a discussion of risk factors.
Investor Verification Checklist
- Verify the regulatory status and approval requirements for stem cell therapy for erectile dysfunction in target international markets.
- Review the full text of the press release (Exhibit 99.1) for specific details on the subsidiary's capitalization and operational timeline.
- Examine the Company's most recent Form 10-K (2017) for historical financial health and existing risk factors.
- Confirm the Company's status as an "emerging growth company" and its election regarding extended transition periods for accounting standards.